EATG » Portfolios

Portfolios

Women and HIV

Globally, women are disproportionally affected by HIV, and constitute more than half of all people living with HIV. Young women and adolescent girls are especially vulnerable, accounting for 46% of…

HIV/TB portfolio

Tuberculosis (TB) is one of the leading causes of death for people living with HIV globally. The EATG operates a portfolio to explore and discuss issues around HIV and TB…

Viral Hepatitis Portfolio

Viral hepatitis (HCV and HBV) remain one of the most important killers of people living with HIV. The EATG has been working in the field of community education and mobilisation,…

HIV Cure Portfolio

In recent years, there has been a renewed scientific focus on curing HIV infection followed by strong interest on the side of community and HIV treatment organizations to support these…

Prevention of HIV infection – PrEP, vaccines, microbicides etc.

The EATG has been engaged in HIV prevention since the earliest years of "Positive Prevention". Partnering primarily with AVAC, we have been operating an extensive and scientifically grounded prevention portfolio…

Access to and affordability of medicines and diagnostics

Recognising that the access to and affordability of medicines is one of the biggest challenges for people living with HIV in WHO Europe, the EAG operates a comprehensive portfolio on…